Cargando…
Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumour growth by non-steroidal anti-inflammatory drugs.
Prostaglandin (PG) E2 biosynthesis in Yoshida hepatoma (AH 130) was evaluated by radioimmunoassay. When hepatoma cells were incubated in vitro, the levels of PGE2 in the medium were similar to those found in hepatocytes for the first 2 h; this was followed by a rapid increase in PGE2 formation, and...
Autores principales: | Trevisani, A., Ferretti, E., Capuzzo, A., Tomasi, V. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1980
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010246/ https://www.ncbi.nlm.nih.gov/pubmed/6248092 |
Ejemplares similares
-
Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130).
por: Dessí, S., et al.
Publicado: (1992) -
Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).
por: Dessì, S., et al.
Publicado: (1995) -
Anti-Tumour Activity of the Fluorescent Dye, Acridine Orange, on Yoshida Sarcoma (Ascites)
por: Korgaonkar, K. S., et al.
Publicado: (1963) -
Isolation of Genes Differentially Expressed between the Yoshida Sarcoma and Long‐survival Yoshida Sarcoma Variants: Origin of Yoshida Sarcoma Revisited
por: Tsuchiya, Haruo, et al.
Publicado: (1994) -
First person – Nagisa Yoshida
Publicado: (2020)